EV/EBITDA
-21.22
-0.16-0.76%
Sat, 22 Feb 2025 00:59:45 GMT
Summary
- As of February 23, 2025, HRTX EV/EBITDA is -21.22, with a fall of -0.16 (-0.76%) during the most recent trading day.
- Over the past year, HRTX EV/EBITDA has dropped by -15.84 (-294.42%).
- HRTX EV/EBITDA is now -102.94% below its all-time high of 722.88.
Performance
HRTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
HRTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -0.8% | +0.8% | +1.2% |
| 1 m1 month | -3.1% | +3.0% | +4.9% |
| 3 m3 months | -29.1% | +29.1% | +56.0% |
| 6 m6 months | -85.3% | -9.6% | -12.4% |
| ytdytd | -6.7% | +6.7% | +11.1% |
| 1 y1 year | -294.4% | -26.4% | -37.3% |
| 5 y5 years | -126.5% | -78.2% | -92.1% |
HRTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.1% | -22.32 | +4.9% | |
| 3 m | 3-month | -16.43 | -29.1% | -25.62 | +17.2% |
| 6 m | 6-month | -10.76 | -97.2% | -25.62 | +17.2% |
| 1 y | 1-year | -5.06 | -319.4% | -25.62 | +17.2% |
| 3 y | 3-year | -1.49 | -1324.2% | -25.62 | +17.2% |
| 5 y | 5-year | -1.49 | -1324.2% | -25.62 | +17.2% |
| alltime | all time | 722.88 | -102.9% | -353.43 | +94.0% |
Heron Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -21.22(+6.7%) |
| 2024 | -19.88(+404.6%) |
| 2023 | -3.94(+58.2%) |
| 2022 | -2.49(-46.5%) |
| 2021 | -4.65(-44.1%) |
| 2020 | -8.32(-19.1%) |
| 2019 | -10.29(-10.1%) |
| 2018 | -11.45(+108.6%) |
| 2017 | -5.49(+67.4%) |
| 2016 | -3.28(-64.7%) |
| 2015 | -9.29(+211.7%) |
| 2014 | -2.98(+14.6%) |
| 2013 | -2.60(-45.7%) |
| 2012 | -4.79(+84.9%) |
| 2011 | -2.59(+13.1%) |
| 2010 | -2.29(-47.0%) |
| 2009 | -4.32(+3223.1%) |
| 2008 | -0.13(-80.3%) |
| 2007 | -0.66(-62.3%) |
| Date | Value |
|---|---|
| 2006 | -1.75(-63.3%) |
| 2005 | -4.77(+8.4%) |
| 2004 | -4.40(-48.1%) |
| 2003 | -8.47(+130.8%) |
| 2002 | -3.67(-49.6%) |
| 2001 | -7.28(-23.2%) |
| 2000 | -9.48(-102.2%) |
| 1999 | 440.75(-638.2%) |
| 1998 | -81.89(-34.9%) |
| 1997 | -125.85(+530.5%) |
| 1996 | -19.96(+53.9%) |
| 1995 | -12.97(+50.5%) |
| 1994 | -8.62(+10.2%) |
| 1993 | -7.82(-62.3%) |
| 1992 | -20.76(-36.2%) |
| 1991 | -32.55(+434.5%) |
| 1990 | -6.09(-72.4%) |
| 1989 | -22.04(+174.8%) |
| 1988 | -8.02(-5.9%) |
| 1987 | -8.52 |
FAQ
- What is Heron Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Heron Therapeutics?
- What is HRTX EV/EBITDA year-to-date change?
- What is Heron Therapeutics EV/EBITDA year-on-year change?
What is Heron Therapeutics EV/EBITDA?
The current EV/EBITDA of HRTX is -21.22
What is the all time high EV/EBITDA for Heron Therapeutics?
Heron Therapeutics all-time high EV/EBITDA is 722.88
What is HRTX EV/EBITDA year-to-date change?
Heron Therapeutics EV/EBITDA has changed by -1.34 (-6.74%) since the beginning of the year
What is Heron Therapeutics EV/EBITDA year-on-year change?
Over the past year, HRTX EV/EBITDA has changed by -15.84 (-294.42%)